Elena Maryamchik
Director of Cell Therapy Laboratory Memorial Sloan Kettering Cancer Center
Seminars
Wednesday 18th November 2026
Automated GMP Manufacturing of γδ-Enriched Tumor-Reactive T Cells using CliniMACS Prodigy: Enabling Decentralized Cell Therapy Production for AML Relapse Prevention
11:30 am
- Generation of tumor-reactive T-cell products from healthy donors and AML patients
- Composition, characterization and functionality of tumor-reactive T-cell products
- Implications for clinical translation and future development
